IO Biotech
Maryann Cimino currently serves as the Director of Investor Relations & Corporate Communications at IO Biotech, a position held since April 2023. Previously, Maryann held various director roles focused on corporate relations and investor communications at Pharvaris and Kiadis Pharma, where responsibilities included stakeholder engagement and corporate affairs. Maryann's extensive experience in corporate communications is further highlighted by a prior role at AMAG Pharmaceuticals, where contributions included managing internal communication initiatives and developing engaging content. Early career positions spanned administrative support roles in leading pharmaceutical firms, culminating in a strong foundation in corporate and organizational communication, supported by multiple degrees from Northeastern University, including a Master of Science in Corporate & Organizational Communication.
This person is not in any teams
This person is not in any offices
IO Biotech
2 followers
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Their pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules.